CRP and depressive disorder: For example, clinical trials of anti-inflammatory medications for depressive disorder should pre-select subgroups of patients with raised inflammatory markers, such as peripheral CRP, as they are more likely to benefit from these treatments (Chamberlain et al. 2019).